Product Information
CEFADROXIL 500 MG/5 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2653 per ML under NDC 68180018202. Its NADAC has been published 522 times since Nov 28, 2013.
FDA first approved this application on Feb 21, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/5mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180018202
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CEFADROXILApproval Type
Generic (ANDA)
FDA Application
ANDA065396FDA Approved
2/21/2008
TE Code
AB
On Market Since
4/23/2008
Pharmacological Classes
Price Statistics
The NADAC for CEFADROXIL 500 MG/5 ML SUSP has been published 522 times since Nov 28, 2013, and over the history we have for it it has declined 43.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2653 per ML |
|---|---|
| All-time high | $0.5553 (Jun 11, 2014) |
| All-time low | $0.2204 (Apr 17, 2024) |
| 52-week high | $0.2927 |
| 52-week low | $0.2567 |
| Median price | $0.3325 |
| Average price | $0.3446 |
| Largest weekly change | -27.4% (Nov 18, 2020) |
| Weeks tracked | 522 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cefadroxil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFADROXIL 500 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFADROXIL 500 MG/5 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $0.2653 per ML (NDC 68180018202), effective Sep 30, 2026.
How has the price of CEFADROXIL 500 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFADROXIL 500 MG/5 ML SUSP has declined 43.3%. It has been tracked across 522 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFADROXIL 500 MG/5 ML SUSP?
Since Nov 28, 2013, the NADAC for CEFADROXIL 500 MG/5 ML SUSP has ranged from a low of $0.2204 (Apr 17, 2024) to a high of $0.5553 (Jun 11, 2014), with a median of $0.3325 per ML.
Are there cheaper alternatives to CEFADROXIL 500 MG/5 ML SUSP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFADROXIL 500 MG/5 ML SUSP, is $0.2243 per ML — about 15% below CEFADROXIL 500 MG/5 ML SUSP.
Who manufactures CEFADROXIL 500 MG/5 ML SUSP?
CEFADROXIL 500 MG/5 ML SUSP (NDC 68180018202) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.